Faculty: Ted Lain, MD – Austin, TX
In this podcast product theater, Dr. Ted Lain reviews Aklief (trifarotene) 0.005% cream, a new topical innovation in the treatment of moderate to severe acne. Aklief is indicated for the treatment of acne vulgaris in patients 9 years and older. It is a topical retinoid that binds to RAR-gamma, which is the most common retinoic acid receptor of the skin. Dr. Lain reports the AAD recommends “retinoids as the core of topical therapy for acne because they are comedolytic, they resolve the precursor microcomedone lesion and they are anti-inflammatory.”